Vesselina COOKE,Michael Scott VISSER,Andrew WYLIE,Padmaja YERRAMILLI-RAO,Xu ZHU
申请号：
US16646390
公开号：
US20200268749A1
申请日:
2018.09.11
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present disclosure relates to use of a protein kinase C (PKC) inhibitor in the treatment or prevention of proliferative diseases. The disclosure also relates to corresponding pharmaceutical formulations, uses, methods, combinations, and related disclosure embodiments. The disclosure further relates to use of a pharmaceutical combination comprising a PKC inhibitor and another therapeutic agent, such as an MDM2 inhibitor, in the treatment or prevention of a proliferative disease.
